Rona Yaeger
0000-0002-7233-5454
Publication & Citation Trends
Publications
0 total
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program.
Cited by 1
Semantic Scholar
Abstract 5063: Ancestry-linked, stage-specific delay to tertiary care is associated with survival differences in colorectal cancer
Cited by 0
Semantic Scholar
722 Defining the Anatomic Landscape of Lymph Node Metastases in Rectal Adenocarcinoma
Cited by 0
Semantic Scholar
Abstract A050: Mutant allele copy number gains define distinct molecular subtypes of oncogene-driven cancers and are associated with response to allele-specific KRASG12C inhibitor sotorasib in NSCLC
Cited by 0
Semantic Scholar
Abstract B034: Genetic and non-genetic mechanisms of resistance to KRAS inhibition in CRC
Cited by 0
Semantic Scholar
Abstract IA014: Combination strategies to overcome adaptive and acquired resistance to RAS targeted therapy in colorectal cancer
Cited by 0
Semantic Scholar
BREAKWATER: Primary analysis of first-line (1L) encorafenib + cetuximab (EC) + FOLFIRI in BRAF V600E-mutant metastatic colorectal cancer (mCRC).
Cited by 1
Semantic Scholar
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma.
Cited by 0
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(535)
Genetic factors in colorectal cancer
(228)
Lung Cancer Treatments and Mutations
(227)
Melanoma and MAPK Pathways
(147)
Cancer Genomics and Diagnostics
(143)
Affiliations
Schneider Electric (France)
MACOM (United States)
Memorial Sloan Kettering Cancer Center
University of California, Los Angeles
University of Pittsburgh